Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for producing levodopa through microbial fermentation and application

A microbial fermentation and levodopa technology, which is applied in the fields of food, feed and medicine, can solve the problems of residual raw materials and large amount of starting raw materials, and achieve the effect of increasing production yield and glucose metabolic flow

Pending Publication Date: 2022-04-26
NANJING SHOUBAI BIOTECH CO
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Using microbial enzyme biotransformation method to produce levodopa has the advantages of low production cost and relatively simple process compared with chemical synthesis and cat bean extraction methods, but there are still problems of large amount of starting raw materials and residual raw materials

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for producing levodopa through microbial fermentation and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0048] This example describes the acquisition of the E. coli 4-hydroxyphenylacetic acid 3-monooxygenase B gene.

[0049] According to the NCBI Reference Sequence published by Pubmed: NC_012971.2: Escherichia coliBL21 (DE3) wild-type 4-hydroxyphenylacetic acid 3-monooxygenase B (the amino acid sequence is shown in SEQ ID NO: 3, and the nucleotide sequence is shown in SEQ ID NO: 4 shows) the nucleotide sequence SEQ ID NO: 4 design primers.

[0050] Forward primer (T7hpaB-F) SEQ ID NO: 5:

[0051] 5'-GGGAATTCCATATGAAACCAGAAGATTTCCGC-3',

[0052] Reverse primer (T7hpaB-R) SEQ ID NO: 6:

[0053] 5'-CGGAATTCATTATTTCAGCAGCTTTATCCAGCAT-3'; Among them, the parts in italics are the enzyme cutting sites NdeI and EcoRI respectively. The PCR reaction was carried out in 50 μl total system, and the reaction conditions were: denaturation at 94°C for 5 minutes; denaturation at 94°C for 30 seconds, annealing at 58°C for 1 minute, extension at 72°C for 2 minutes, a total of 30 cycles; extensi...

Embodiment 2

[0055] This example describes the construction of a wild-type 4-hydroxyphenylacetic acid 3-monooxygenase B gene expression vector.

[0056] The PCR product in Example 1 was subjected to agarose gel electrophoresis, and the target fragment was recovered according to the instructions of the gel recovery kit. Take 100 μl of the PCR product and digest it with restriction endonucleases NdeI and EcoRI, and then connect it to the hpaC / pET-24a vector digested with NdeI and EcoRI (hpaC is 4-hydroxyphenylacetic acid 3-monooxygenase C, previously inserted into the pET-24a vector), the ligation product mixture was transformed into Escherichia coli Top10, 20 clones were picked, and PCR identification was performed with primers T7hpaB-F and T7hpaB-R. The positive clones identified by PCR were selected for sequence determination, and the vectors with correct sequencing were saved and named: pET-hpaBC.

Embodiment 3

[0058] This example describes error-prone PCR amplification of the E. coli 4-hydroxyphenylacetic acid 3-monooxygenase B gene.

[0059] Utilizing the property that Taq DNA polymerase does not have 3'-5' proofreading function, under the concentration of high magnesium ion concentration (8mmol / L) and different concentration of dNTP (wherein the concentration of dATP and dGTP is 1.5mmol / L, the concentration of dTTP and dCTP 3.0mmol / L) to control the frequency of random mutations, introduce random mutations into the target gene, and construct a mutation library. Template concentration A 260 The value is 1000ng / mL, the enzyme concentration is 5U / μL, and the primer concentration is 100μM.

[0060] Error-prone PCR reaction system (50μl): 5μl of 10×PCR reaction buffer, 5μl of dNTP (2.5nM), MgCl 2 5 μl, forward primer (T7hpaB-F) 1 μl, reverse primer (T7hpaB-R) 1 μl, DNA template (PCR product of Example 1) 1 μl, Taq DNA polymerase 0.5 μl, ddH 2 O 31.5 μl.

[0061]PCR program: pre-den...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Wavelengthaaaaaaaaaa
Login to View More

Abstract

The invention discloses a method for producing levodopa through microbial fermentation. According to the method, levodopa is produced with higher efficiency and higher yield mainly by improving the effect of 4-hydroxyphenylacetic acid 3-monooxygenase B (hpaB) in microorganisms.

Description

technical field [0001] The invention relates to a high-yield levodopa genetically engineered Escherichia coli strain and a construction method thereof, and a method for fermenting and producing levodopa by using the strain. The present invention also relates to a method for recovering levodopa from a fermentation process. It belongs to the field of medicine, food and feed. Background technique [0002] Levodopa (L-DOPA), chemical name: 3-hydroxy-L-tyrosine. Chinese synonyms: L-3-(3,4-dihydroxyphenyl)alanine; L-B-(3,4-dihydroxyphenyl)alanine; L-β-(3,4-dihydroxyphenyl)alanine acid; levodopa; 3-(3,4-dihydroxyphenyl)-L-alanine; L-3-(3,4-dihydroxyphenyl)alanine. Levodopa is a white or off-white crystalline powder, easily soluble in dilute acid, slightly soluble in water, insoluble in ethanol, ether or chloroform, odorless, tasteless, and turns black in the air. [0003] Levodopa is an important biologically active substance in organisms and an important intermediate product i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12P13/22C12N9/02C12N15/53C12N15/70C12N1/21C12R1/19
CPCC12P13/225C12N9/0071C12N15/70C12Y114/14009
Inventor 邹季虹
Owner NANJING SHOUBAI BIOTECH CO
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com